[Symposium on pharmacokinetics and technics of antineoplastic agent studies].
出版信息
Minerva Med. 1971 Apr 7;62(28):1488-90.
PMID:5567643
Abstract
摘要
相似文献
1
[Symposium on pharmacokinetics and technics of antineoplastic agent studies].[抗肿瘤药物的药代动力学与技术研讨会]
Minerva Med. 1971 Apr 7;62(28):1488-90.
2
Therapeutic strategies for targeting mononuclear phagocytes in cancer.
J Pediatr Hematol Oncol. 2009 Jan;31(1):14-7. doi: 10.1097/MPH.0b013e31816e236a.
3
[Antitumor immunoadjuvant activity and the immunoregulatory mechanisms of yeasts and their components].[酵母及其成分的抗肿瘤免疫佐剂活性和免疫调节机制]
Ann Ist Super Sanita. 1982;18(3):501-8.
4
[Common principles of antineoplastic chemotherapy and their theoretical basis].[抗肿瘤化疗的共同原则及其理论基础]
Vnitr Lek. 1979 Feb;25(2):178-83.
5
[Phase I clinical study of a new fluorinated pyrimidine antineoplastic agent, TAC-278].新型氟化嘧啶抗肿瘤药TAC-278的I期临床研究
Gan To Kagaku Ryoho. 1982 Mar;9(3):443-56.
6
Pharmacokinetics of Cytembena in man.西替苯那在人体中的药代动力学。
Neoplasma. 1971;18(5):447-54.
7
Cancer and its treatments, and the reticulo-endothelial system in man.癌症及其治疗方法，以及人体中的网状内皮系统。
Br J Surg. 1968 Nov;55(11):872.
8
Pharmacological and toxicological studies of a new antitumor polysaccharide, schizophyllan.
Arzneimittelforschung. 1982;32(6):647-56.
9
[Study of Lycurim pharmacokinetics in man].
Acta Pharm Hung. 1978;48 Suppl:49-51.
10
[Do cytostatics change the histopathology of leukemias?].[细胞抑制剂会改变白血病的组织病理学吗？]
Rev Med Chil. 1971 Aug;99(8):566-71.
Zotero 插件